Resumen de Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer‑associated thrombosis patients’ healthcare in Spain

Andrés Jesús Muñoz Martín, A. Javier Trujillo-Santos, Edelmira Martí Sáez, Luis Jara Palomares, Pedro Ruiz Artacho, Raquel Macias Montero, Enrique Gallardo-Díaz, Juan J. López Núñez, Elena Brozos Vázquez, Verónica Robles, Pedro Pérez Segura

• Cancer patients are at risk of venous thromboembolism (VTE), its recurrence, but also at risk of bleeding while anticoagulated. In addition, cancer therapies have been associated to increased VTE risk. Guidelines for VTE treatment in cancer patients recommend low molecular weight heparins (LMWH) or direct oral anticoagulants (DOAC) for the initial treatment, DOAC for VTE short-term treatment, and LMWH or DOAC for VTE long-term treatment. This consensus article arises from a collaboration between diferent Spanish experts on cancer-associated thrombosis. It aims to reach an agreement on a practical document of recommendations for action allowing the healthcare homogenization of cancer-associated thrombosis (CAT) patients in Spain considering not only what is known about VTE management in cancer patients but also what is done in Spanish hospitals in the clinical practice. The text summarizes the current knowledge and available evidence on the subject in Spain and provides a series of practical recommendations for CAT management and treatment algorithms to help clinicians to manage CAT over time.